Skip to main content

Enter a phrase above to search within the site.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

FAQs
A Wearable Alcohol Biosensor - A Second Challenge We would be remiss if we didn’t recognize that this Challenge is just that, a challenge. We are aware that the criteria may be difficult to meet on all accounts. However, that is why we have posted the challenge. All submissions will be judged based upon how much the solution meets all...
NIAAA COVID-19 Notice of Special Interest (NOSI) and Other NIH Funding Opportunities

NIAAA has issued a Notice of Special Interest (NOSI) for administrative supplements and competitive revisions focused on urgent research questions of significance to alcohol and the COVID-19 pandemic ( NOT-AA-20-11 ). NIAAA is also participating in other NIH NOSIs and funding opportunities focused on COVID-19 research questions. These NOSIs are linked to PA-18-591 (administrative supplement) and PA-18-935 (urgent competitive revision)...

Applications Requesting $500,000 or More in Direct Costs
The National Institutes of Health (NIH) has updated its policy on the acceptance of applications requesting direct costs of $500,000 or more for any one year. Effective with the January 1, 2002 receipt dates, applicants must seek agreement to accept assignment from Institute/Center staff at least 6 weeks prior to the anticipated submission of any application requesting $500,000 or more...
Medications Development for the Treatment of Alcohol Use Disorder and Alcohol-Related Organ Damage (Re-issue of RFA 19-005)
Joanne Fertig, Ph.D. and Kathy Jung, Ph.D. Purpose During the past two decades progress has been made in developing medications to treat Alcohol Use Disorders (AUD). Currently there are only three Food and Drug (FDA)-approved medications for the treatment of AUD: disulfiram, oral and long-term injectable naltrexone, and acamprosate. However, given the heterogenous nature of AUD, many individuals show only...
HIV Prevention and Alcohol
Kendall Bryant, Ph.D., Office of the Director, NIAAA Purpose This NIAAA-led NOFO calls for research proposals supported by the research grant mechanisms R01 and associated announcement R34 for intervention development. The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for...
Mechanisms of Alcohol-associated Cancers (Clinical Trial Not Allowed, R01, R21)
Gary Murray, Ph.D., Kathy Jung, Ph.D., Bill Dunty, Ph.D. Replaces PA-17-220 and PA-17-219 Mechanisms of Alcohol-associated Cancers (Clinical Trial Not Allowed, R01/R21): Expiring September 8, 2020. Purpose This notice highlights interest in receiving investigator-initiated grant applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. Epidemiological and biological research has established that chronic or excessive alcohol consumption...

Advisory Council Minutes

Minutes of the 142nd Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM 142nd Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM June 9, 2016 The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 142nd meeting at 10:17 a.m. on Thursday, June 9, 2016, at NIAAA headquarters in Rockville...

The National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Concept Clearance
Benjamin Xu, Ph.D., Division of Neuroscience and Behavior Purpose The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA), a nation-wide consortium of five research project sites to study the impact of alcohol drinking on brain structure and function during adolescence and into early adulthood. Background Adolescent or...
Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes
Gregory Bloss, Division of Epidemiology and Prevention Research Participating IC: NIDA, NCI Purpose The purpose of this announcement is to replace a series of recently expired NIAAA-issued Program Announcements ( PA-17-132 , PA-17-134 , PA-17-135 ) to communicate support for research topics of interest to the Division of Epidemiology and Prevention Research at the National Institute on Alcohol Abuse and...

Announcement

CRAN Will Host a Pre-Application Technical Assistance Webinar for the ABCD Study
This is a correction to the webex connection information for the ABCD pre-application technical assistance webinar, which will be conducted on Tuesday, February 24, 2015 from 1:00 to 2:30 p.m. EST to discuss the three new Adolescent Brain Cognitive Development (ABCD) Longitudinal Study funding opportunities: (1) a set of research project sites ( RFA-DA-15-015 ), (2) a single central data...

Announcement

Notice of Funding Opportunities for Collaborative Research on Addiction at NIH (CRAN)

NIDA, NIAAA, and NCI announce the release of 2 new NOFOs to promote the goals of Collaborative Research on Addiction at NIH (CRAN; formerly known as functional integration). Its mission is to provide a strong collaborative framework for enabling NIDA, NIAAA, and NCI to pool resources and expertise, creating synergies in addiction science, addressing new research opportunities, and meeting the...

Announcement

New Funding Opportunity: Dynamic Neuroimmune Interactions in the Transition from Brain Function to Dysfunction, RFA-AA-18-007

NIAAA has issued the following RFA for the NIH Blueprint for Neuroscience Research Dynamic Neuroimmune Interactions in the Transition from Brain Function to Dysfunction RFA-AA-18-007, R01 https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-18-007.html The goal of this NOFO is to transform our understanding of how dynamic interactions among multiple cell types involved in neuroimmune interactions (e.g., neurons, glia cells, neurovascular units, or other neuroimmune components) mediate...

Announcement

NIH issues new funding opportunities for research to improve treatment outcomes for substance use disorders

The Collaborative Research on Addiction at NIH (CRAN ) has published two Notice of Funding Opportunities (NOFOs) on "Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33) and (R21/R33). Areas supported by this NOFO include research to generate and conduct preliminary tests of targeted addiction treatment to address multiple substances, which may include alcohol, tobacco...

Advisory Council Minutes

Minutes of the 151st Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM
DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM 151st Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM May 14, 2019 Bethesda. Maryland​ The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 151st meeting at 9:00 a.m. on Tuesday, May 14, 2019, at NIAAA headquarters...
Council Clearance for IND-enabling Small Business NOFO
Title: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and Alcohol-Associated Organ Damage (AAOD) Authors : Jenica Patterson, Ph.D; Megan Ryan, M.B.A.; Raye Litten, Ph.D.; Kathy Jung, Ph.D. Purpose: DTR intends to re-issue PAR 18-578 “Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and Alcohol-Related Organ Damage (U44)”...
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD)
Joe Wang, Division of Metabolism and Health Effects Purpose The purpose of the proposed NOFOs is to solicit applications to continue the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) consortium. CIFASD is an NIAAA-funded initiative conducting Fetal Alcohol Spectrum Disorders (FASD) research through multidisciplinary and collaborative approaches. Applications responsive to these NOFOs should address urgent and important issues around...
Alcohol and HIV/AIDS - Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research
Kendall Bryant, Ph.D. Purpose The future Notice of Funding Opportunity (NOFO, a reissue of RFA AA 16-001 ) will solicit applications for human studies that will advance operations or implementation research in the context of alcohol and HIV/AIDS by facilitating the development of: (1) broader systems approaches for monitoring complex HIV and alcohol-related morbidity and mortality, and (2) interventions to...
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Re-issue of PAR 19 207 Participating IC’s: NIAAA, NIDA Authors: Laura Kwako, NIAAA, Albert Avila, NIDA Purpose : The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIAAA/NIDA R25 program is to support educational activities that foster a better understanding of biomedical, behavioral, and clinical research on...
Cross-Cutting Translational Research on the interaction of HIV and Alcohol
Title: Cross-Cutting Translational Research on the interaction of HIV and Alcohol Authors: Kendall Bryant, Ph.D., Joe Wang, Ph.D., Division of Metabolism and Health Effects Mechanism: RFA: R01, R21, R34 Purpose: The purpose of this research initiative is to encourage mechanistic studies that explore alcohol’s effects on the gut-liver-brain interactions and their pathological consequences among HIV/AIDS patients that can be translated...
Looking for U.S. government information and services?
Visit USA.gov